MedTrace Logo

Physical Activity After Cardiac Arrest; a Sub-study in the Target Temperature Management Trial 2

NCT03543332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2021-09-16

No results posted yet for this study

Summary

The Target Temperature Management trial 2 (TTM2) is an international multi-center study, that randomize patients with OHCA of a presumed cardiac or unknown cause to target temperature management at 33°C or normothermia but avoiding fever (37.8°C) for the first 24 hours after the OHCA. The TTM2 study (clinicaltrials.gov Identifier NCT02908308) includes a detailed follow-up of functional outcome, health-related quality of life and neurocognitive function at 6 and 24 months post-arrest. This protocol describes a sub-study within the TTM2 trial that specifically focus on physical activity among the OHCA survivors.

Conditions

  • Heart Arrest, Out-Of-Hospital
  • Physical Activity

Interventions

DIAGNOSTIC_TEST

Measures of physical activity and kinesiophobia

Groups will be compared regarding kinesiophobia with TSK heart.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Halmstad County Hospital

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Niklas Nielsen, MD PhD · Lund University

  • Gisela Lilja, OT PhD · Lund University

  • Tobias Cronberg, PhD MD · Lund University

  • Åsa B Tornberg, RPT PhD · Lund University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-21
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • Denmark
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543332 on ClinicalTrials.gov